{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:03:46Z","timestamp":1648746226464},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[1984,12,1]],"date-time":"1984-12-01T00:00:00Z","timestamp":470707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1984,12]]},"DOI":"10.1007\/bf01712183","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T06:17:05Z","timestamp":1118557025000},"page":"1165-1169","source":"Crossref","is-referenced-by-count":2,"title":["Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses"],"prefix":"10.1007","volume":"62","author":[{"given":"M.","family":"Reitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Egbring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gutjahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01712183_CR1","first-page":"189","volume":"5","author":"HD Bruhn","year":"1976","unstructured":"Bruhn HD, Heimburger N (1976) Factor VIII-Related Antigen and Cold-Insoluble Globulin in Leukemias and Carcinomas. Haemostasis 5:189","journal-title":"Haemostasis"},{"key":"BF01712183_CR2","first-page":"443","volume-title":"Leuk\u00e4mie","author":"R Egbring","year":"1972","unstructured":"Egbring R, Trobisch H, Havemann K, Malchow H (1972) Untersuchungen zur Blutungsneigung bei akuten Leuk\u00e4mien. In: Gross R, van de Loo J (eds) Leuk\u00e4mie. Springer, Berlin, Heidelberg New York, pp 443\u2013447"},{"key":"BF01712183_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01631421","volume":"27","author":"R Egbring","year":"1973","unstructured":"Egbring R, Schmidt W, Havemann K (1973) Die vereinfachte radiologische Faktor XIII-Bestimmung und ihre klinische Anwendung bei kongenitalem Faktor XIII-Mangel. Blut 27:6\u201319","journal-title":"Blut"},{"key":"BF01712183_CR4","first-page":"130","volume":"78","author":"H Gadner","year":"1977","unstructured":"Gadner H, Riehm H (1977) Ver\u00e4nderungen der H\u00e4mostase w\u00e4hrend der Induktionstherapic akuter lymphoblastischer Leuk\u00e4mien im Kindesalter. In: G\u00f6bel V (ed) B\u00fccherei des P\u00e4diaters. Ferdinand Enke, Stuttgart, 78:130\u2013139","journal-title":"Ferdinand Enke, Stuttgart"},{"key":"BF01712183_CR5","first-page":"27","volume-title":"Factor XIII and Fibronectin","author":"M Gramse","year":"1983","unstructured":"Gramse M, Egbring R, Havemann K (1983) Detection of granulocytic elastase (ELP) and chymotrypsin (CLP) in acute leukemia in relation to factor XIII deficiency. In: Egbring R, Klingemann H-G (eds) Factor XIII and Fibronectin. Medizinische Verlagsgesellschaft, Marburg, pp 27\u201330"},{"key":"BF01712183_CR6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/BF01651269","volume":"55","author":"K Havemann","year":"1977","unstructured":"Havemann K, Egbring R, Gropp C, Schmidt R, Sodomann CP (1977) Faktor XIII-Mangel bei akuter Leuk\u00e4mie des Erwachsenen: Ergebnisse einer Substitution mit Faktor XIII. Klin Wochenschr 55:801\u2013809","journal-title":"Klin Wochenschr"},{"key":"BF01712183_CR7","first-page":"146","volume-title":"Forschungsergebnisse der Transfusionsmedizin und Immunh\u00e4matologie","author":"F Haghau","year":"1979","unstructured":"Haghau F, Rasche H (1979) Faktor XIII-Substitutionen bei Patienten mit akuter Leuk\u00e4mie. In: Vinazzer H (ed) Forschungsergebnisse der Transfusionsmedizin und Immunh\u00e4matologie. Medicus, Berlin, pp 146\u2013150"},{"key":"BF01712183_CR8","first-page":"1144","volume":"81","author":"K Hasler","year":"1975","unstructured":"Hasler K, B\u00f6ttcher D (1975) Gerinnungsuntersuchungen bei akuter Leuk\u00e4mie. Verh Dtsch Ges Inn Med 81:1144\u20131147","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"BF01712183_CR9","first-page":"3","volume-title":"Gerinnungsfaktor XIII","author":"N Heimburger","year":"1983","unstructured":"Heimburger N, Karges HE (1983) Biochemie und Funktion des F XIII. In: Br\u00fcckner WL (ed) Gerinnungsfaktor XIII. Urban Schwarzenberg, M\u00fcnchen Wien Baltimore, pp 3\u201313"},{"key":"BF01712183_CR10","first-page":"159","volume-title":"Die Thromboembolien","author":"HW Heydern v","year":"1979","unstructured":"Heydern HW v (1979) H\u00e4morrhagische Diathesen bei neoplastischen Erkrankungen. In: K\u00f6stering H (ed) Die Thromboembolien. Roche, Basel Grenzach-Wyhlen, pp 159\u2013165"},{"key":"BF01712183_CR11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0092-8674(78)90272-6","volume":"15","author":"RO Hynes","year":"1978","unstructured":"Hynes RO, Destree AT (1978) Relationship between fibronectin (LETS protein) and actin. Cell 15:875\u2013886","journal-title":"Cell"},{"key":"BF01712183_CR12","first-page":"531","volume-title":"Topics in Hematology. International Congress Series No. 415","author":"HE Karges","year":"1976","unstructured":"Karges HE, Heimburger N (1976) A rapid screening and quantitative assay of clotting F XIII activity. In: Seno S, Takaku F, Irino S (eds) Topics in Hematology. International Congress Series No. 415. Exerpta Medica, Amsterdam Oxford, pp 531\u2013533"},{"key":"BF01712183_CR13","first-page":"267","volume":"185","author":"M Kreissel","year":"1973","unstructured":"Kreissel M, Oehme J (1973) Faktor XIII-Aktivit\u00e4t im Plasma bei akuter Leuk\u00e4mie im Kindesalter. Klin Paediatr 185:267\u2013270","journal-title":"Klin Paediatr"},{"key":"BF01712183_CR14","first-page":"81","volume":"23","author":"B Laursen","year":"1976","unstructured":"Laursen B (1976) Fibrinolysis and Antithrombin in Acute Leukemia. Dan Med Bull 23:81\u201386","journal-title":"Dan Med Bull"},{"key":"BF01712183_CR15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/1097-0142(19820801)50:3<451::AID-CNCR2820500312>3.0.CO;2-4","volume":"50","author":"HA Liebmann","year":"1982","unstructured":"Liebmann HA, Wada JK, Patch MJ, McGehee W (1982) Depression of Functional and Antigenic Plasma Antithrombin III (AT III) Due to therapy with L-Asparaginase. Cancer 50:451\u2013456","journal-title":"Cancer"},{"key":"BF01712183_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0019-2791(65)90004-2","volume":"2","author":"G Mancini","year":"1965","unstructured":"Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235\u2013254","journal-title":"Immunochemistry"},{"key":"BF01712183_CR17","first-page":"4295","volume":"31","author":"R Marx","year":"1981","unstructured":"Marx R (1981) Antithrombin III: praktische Bedeutung und neues therapeutisches Prinzip. Therapiewoche 31:4295\u20134307","journal-title":"Therapiewoche"},{"key":"BF01712183_CR18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1172\/JCI106053","volume":"48","author":"J McDonagh","year":"1969","unstructured":"McDonagh J, McDonagh RP, Delage JM, Wagner RH (1969) Factor XIII in Human Plasma and Platelets. J Clin Invest 48:940\u2013946","journal-title":"J Clin Invest"},{"key":"BF01712183_CR19","first-page":"111","volume":"5","author":"DF Moscher","year":"1980","unstructured":"Moscher DF (1980) Fibronectin. Prog Hemostasis Thromb 5:111\u2013151","journal-title":"Prog Hemostasis Thromb"},{"key":"BF01712183_CR20","unstructured":"Oehme J, Gutjahr P (1981) Krebs bei Kindern und Jugendlichen. Ein Leitfaden f\u00fcr Studium, Praxis und Klinik. Deutscher \u00c4rzteverlag, K\u00f6ln-L\u00f6wenich"},{"key":"BF01712183_CR21","first-page":"271","volume":"81","author":"K Oster","year":"1973","unstructured":"Oster K, Linnemann R (1973) Measurement of C1-Inactivator (Alpha 2-Neuraminoglycoprotein) on Human Blast Cells in Blast Leukemia. Acta Pathol Microbiol Scand B 81:271\u2013272","journal-title":"Acta Pathol Microbiol Scand B"},{"key":"BF01712183_CR22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-2008-1070350","volume":"106","author":"G Pott","year":"1981","unstructured":"Pott G, Lohmann J, Zundorf P, Gerlach U (1981) Vermindertes Fibronection im Plasma bei Patienten mit Sepsis und Schock. Dtsch Med Wochenschr 106:532\u2013535","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01712183_CR23","first-page":"348","volume-title":"H\u00e4mostase, Thromboembolie, Arteriosklerose","author":"H Pralle","year":"1982","unstructured":"Pralle H, Sch\u00f6ndorff TH, Graubner M (1982) Antithrombin III (AT III)-Mangel unter L-Asparaginasetherapie. In: Van de Loo J, Asbeck F (eds) H\u00e4mostase, Thromboembolie, Arteriosklerose. Schattauer, Stuttgart New York, pp 348\u2013351"},{"key":"BF01712183_CR24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3476(82)80535-0","volume":"100","author":"JR Priest","year":"1982","unstructured":"Priest JR, Ramsay NKC, Steinherz PG, Tubergen DG, Cairo MS, Sitarz AL, Bishop AJ, White L, Trigg ME, Levitt CJ, Cich JA, Coccia PF (1982) A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood lymphoblastic leukemia. J Pediatr 100:984\u2013989","journal-title":"J Pediatr"},{"key":"BF01712183_CR25","first-page":"900","volume":"100","author":"JR Priest","year":"1982","unstructured":"Priest JR, Ramsay NKC, Bennett AJ, Krivit W, Edson JR (1982) The effect of L-asparaginase on antithrombin, plasminogen and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 100:900\u2013995","journal-title":"J Pediatr"},{"key":"BF01712183_CR26","first-page":"84","volume":"3","author":"K Ranft","year":"1978","unstructured":"Ranft K (1978) Faktor XIII-Bestimmung: Indikation und Aussagewert vom internistischen Standpunkt. Diagnostik und Intensivther 3:84\u201389","journal-title":"Diagnostik und Intensivther"},{"key":"BF01712183_CR27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/BF01486998","volume":"50","author":"H Rasche","year":"1972","unstructured":"Rasche H, Dietrich M, Hiemeyer V (1972) Untersuchungen \u00fcber die Faktor XIII-Aktivit\u00e4t im Plasma bei akuter Leuk\u00e4mie. Klin Wochenschr 50:1017\u20131019","journal-title":"Klin Wochenschr"},{"key":"BF01712183_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01633949","volume":"30","author":"H Rasche","year":"1975","unstructured":"Rasche H, Dietrich M (1975) Die H\u00e4mostasest\u00f6rung der akuten Leuk\u00e4mie. Blut 30:153\u2013162","journal-title":"Blut"},{"key":"BF01712183_CR29","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1055\/s-2008-1070225","volume":"107","author":"H Rasche","year":"1982","unstructured":"Rasche H, Haghou F, Gaus W, Dietrich M, Hoelzer D, Pflieger H, Kurrle E, Pindur G, Seifried E, Heimpel H (1982) Gerinnungsfaktor XIII-Substitution bei akuter Leuk\u00e4mie. Dtsch Med Wochenschr 107:1882\u20131886","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01712183_CR30","first-page":"199","volume":"45","author":"TH Sch\u00f6ndorf","year":"1982","unstructured":"Sch\u00f6ndorf TH, Pralle H, Graubner M (1982) Hypercoagulability Due to Antithrombin-III-Decrease under Longterm Asparaginase Administration. Blut 45:199","journal-title":"Blut"},{"key":"BF01712183_CR31","first-page":"263","volume-title":"Factor XIII and Fibronectin","author":"HP Schwarz","year":"1983","unstructured":"Schwarz HP, Aiginger P, Kuzmits R (1983) Fibronectin plasma concentrations in patients with malignant diseases. In: Egbring R, Klingemann H-G (eds) Factor XIII and Fibronectin. Medizinische Verlagsgesellschaft, Marburg, pp 263\u2013367"},{"key":"BF01712183_CR32","first-page":"217","volume":"191","author":"AH Sutor","year":"1979","unstructured":"Sutor AH (1979) Zur Blutungsproblematik bei akuten myeloischen Leuk\u00e4mien Klin P\u00e4diatr 191:217\u2013224","journal-title":"Zur Blutungsproblematik bei akuten myeloischen Leuk\u00e4mien Klin P\u00e4diatr"},{"key":"BF01712183_CR33","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1055\/s-0028-1104287","volume":"101","author":"H Trobisch","year":"1976","unstructured":"Trobisch H, Egbring R (1976) H\u00e4mostatische Defekte bei akuten myeloischen Leuk\u00e4mien des Erwachsenen. Pathophysiologie und Therapie. Dtsch Med Wochenschr 101:1430\u20131433","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01712183_CR34","first-page":"83","volume-title":"Gerinnungsfaktor XIII","author":"H Trobisch","year":"1983","unstructured":"Trobisch H (1983) Bedeutung des Gerinnungsfaktors XIII bei der akuten myeloischen Leuk\u00e4mie des Erwachsenen. In: Br\u00fcckner WL (ed) Gerinnungsfaktor XIII. Urban Schwarzenberg, M\u00fcnchen Wien Baltimore, pp 83\u201392"},{"key":"BF01712183_CR35","first-page":"147","volume-title":"Factor XIII and Fibronectin","author":"T Tsukada","year":"1983","unstructured":"Tsukada T (1983) Factor XIII and Transamidase activities in human blood platelets. In: Egbring R, Klingemann H-G (eds) Factor XIII and Fibronectin. Medizinische Verlagsgesellschaft, Marburg, pp 147\u2013157"},{"key":"BF01712183_CR36","first-page":"26","volume":"6","author":"K Winkler","year":"1983","unstructured":"Winkler K, Beron G, Th\u00f6ne I, J\u00fcrgens H, Goebel U, Gutjahr P, Spaar H-J, Drescher J, Thomas P, M\u00fcller-Wickup J, Landbeck G (1983) Therapie der akuten Lymphoblastenleuk\u00e4mie im Kindesalter. Multizentrische prospektive Therapiestudie COALL-80. Onkologie 6:26\u201332","journal-title":"Onkologie"},{"key":"BF01712183_CR37","first-page":"186","volume":"5","author":"K-H Zurborn","year":"1982","unstructured":"Zurborn K-H, Bensmeier R, Schamerowski F, St\u00f6hr A, Bruhn HD (1982) Gerinnungsst\u00f6rungen bei Tumoren und H\u00e4moblastosen. Onkologie 5:186\u2013190","journal-title":"Onkologie"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01712183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T12:54:14Z","timestamp":1557320054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01712183"}},"subtitle":["Behaviour before and during treatment according to protocol I of the cooperative leukaemia study COALL-80"],"short-title":[],"issued":{"date-parts":[[1984,12]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[1984,12]]}},"alternative-id":["BF01712183"],"URL":"https:\/\/doi.org\/10.1007\/bf01712183","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,12]]}}}